Having trouble viewing this email? View in your browser.
ESCMID Logo

26 September 2017
WEEKLY NEWS

Dear colleagues,

Several ESCMID representatives contributed to a new report published by WHO, which found very few potential treatment options for the most threatening antibiotic-resistant infections. The core report is complemented by an updated document describing their priority pathogen list.

EITaF published new commentaries on its webpage about the ECDC report, detailing clusters of autochthonous chikungunya cases in Rome and Anzio (Italy), and the new European Medical Corps.

This is the last week to apply for the Medical Guidelines Director position at ESCMID. Qualified candidates are invited to send their application to ESCMID’s Publications and Communications Officer, Murat Akova, before 30 September 2017.

ESCMID Executive Office
Aeschenvorstadt 55
4051 Basel
Switzerland
Phone +41 61 508 0150
info@escmid.org
Follow ESCMID
Visit us on mastodon Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions .